SCHEMBL3222115

SCHEMBL3222115

CCC=CCC=CCC=CCC=CCCC=CCC(CCC)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRIK1 P39086 2/20 0.50
▸ GRIK2 Q13002 2/20 0.50
▸ ALDH1A1 P00352 7/20 0.49
▸ CYP19A1 P11511 4/20 0.49
▸ MAPT P10636 4/20 0.49
▸ PPARG P37231 3/20 0.49
▸ OXER1 Q8TDS5 3/20 0.49
▸ RXRA P19793 2/20 0.49
▸ FFAR1 O14842 2/20 0.49
▸ TDP1 Q9NUW8 2/20 0.48
▸ CHRM1 P11229 1/20 0.48
▸ AKR1A1 P14550 1/20 0.48
▸ CHRM3 P20309 1/20 0.48
▸ HTR2A P28223 1/20 0.48
▸ HTR2C P28335 1/20 0.48
▸ ADRA1A P35348 1/20 0.48
▸ HRH1 P35367 1/20 0.48
▸ DRD3 P35462 1/20 0.48
▸ SLC6A3 Q01959 1/20 0.48
▸ HDAC1 Q13547 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3222107 1.00 GRIK1 (0.50) GRIK1GRIK2ALDH1A1CYP19A1MAPT
SCHEMBL3821557 0.95 GRIK1 (0.54) GRIK1GRIK2ALDH1A1CYP19A1MAPT
SCHEMBL3821562 0.95 GRIK1 (0.54) GRIK1GRIK2ALDH1A1CYP19A1MAPT
SCHEMBL3821560 0.95 GRIK1 (0.54) GRIK1GRIK2ALDH1A1CYP19A1MAPT
SCHEMBL3215976 0.86 GRIK1 (0.53) GRIK1GRIK2ALDH1A1CYP19A1MAPT
SCHEMBL3215984 0.86 GRIK1 (0.53) GRIK1GRIK2ALDH1A1CYP19A1MAPT
SCHEMBL28586104 0.84 CHRM1 (0.58) GRIK1GRIK2ALDH1A1FFAR1TDP1
SCHEMBL28498553 0.84 CHRM1 (0.58) GRIK1GRIK2ALDH1A1FFAR1TDP1
SCHEMBL13491253 0.83 ADORA3 (0.49) GRIK1GRIK2ALDH1A1CYP19A1MAPT
SCHEMBL27128215 0.82 FFAR1 (0.49) GRIK1GRIK2MAPTFFAR1PPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399516-B2 Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (PPAR) PRONOVA BIOPHARMA NORGE AS (NO) 2013-03-19 — — US disclosed
US-20100035990-A1 ALPHA-SUBSTITUTED OMEGA-3 LIPIDS THAT ARE ACTIVATORS OR MODULATORS OF THE PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR (PPAR) PRONOVA BIOPHARMA NORGE AS (NO) 2010-02-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100035990-A1 ALPHA-SUBSTITUTED OMEGA-3 LIPIDS THAT ARE ACTIVATORS OR MODULATORS OF THE PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR (PPAR) PPARG, PPARA, FFAR3 GRIK1 1414/4885GRIK2 918/4885ALDH1A1 1088/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback